These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29473173)

  • 61. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
    Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.
    Seftel MD; Growe GH; Petraszko T; Benny WB; Le A; Lee CY; Spinelli JJ; Sutherland HJ; Tsang P; Hogge DE
    Blood; 2004 Jan; 103(1):333-9. PubMed ID: 12958065
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen-reduced platelets in mice.
    Jackman RP; Heitman JW; Muench MO
    Vox Sang; 2020 Jul; 115(5):367-376. PubMed ID: 32201962
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention and circumvention of refractoriness to platelet transfusions: interface between preparative and therapeutic apheresis.
    Beris P; Dornier C
    Curr Stud Hematol Blood Transfus; 1990; (57):267-76. PubMed ID: 2272206
    [No Abstract]   [Full Text] [Related]  

  • 66. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
    Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
    Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibodies to private and public HLA class I epitopes in platelet recipients.
    Zimmermann R; Wittmann G; Zingsem J; Blasczyk R; Weisbach V; Eckstein R
    Transfusion; 1999 Jul; 39(7):772-80. PubMed ID: 10413287
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors.
    Vox Sang; 2003 Jan; 84(1):73-88. PubMed ID: 12542737
    [No Abstract]   [Full Text] [Related]  

  • 69. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products.
    Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A
    Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Study of CD69 antigen expression and integrity of leukocyte cellular membrane in stored platelet concentrates following irradiation and treatment with Mirasol® PRT System.
    Lachert E; Woźniak J; Antoniewicz-Papis J; Krzywdzińska A; Kubis J; Mikołowska A; Letowska M
    Adv Clin Exp Med; 2017; 26(1):7-13. PubMed ID: 28397426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness.
    Beligaswatte A; Tsiopelas E; Humphreys I; Bennett G; Robinson K; Davis K; Bardy P
    Br J Haematol; 2013 Aug; 162(3):409-12. PubMed ID: 23651440
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
    Schiffer CA; Dutcher JP; Aisner J; Hogge D; Wiernik PH; Reilly JP
    Blood; 1983 Oct; 62(4):815-20. PubMed ID: 6349715
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [HLA and transfusion: new approaches with Luminex™ technology].
    Giannoli C; Nguyen TK; Dubois V
    Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model.
    Slichter SJ; Pellham E; Bailey SL; Christoffel T; Gettinger I; Gaur L; Latchman Y; Nelson K; Bolgiano D
    Blood; 2017 Aug; 130(8):1052-1061. PubMed ID: 28705838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
    Ignatova AA; Karpova OV; Trakhtman PE; Rumiantsev SA; Panteleev MA
    Vox Sang; 2016 Apr; 110(3):244-52. PubMed ID: 26646605
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.
    Brand A; Claas FH; Voogt PJ; Wasser MN; Eernisse JG
    Vox Sang; 1988; 54(3):160-6. PubMed ID: 3369136
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
    Seghatchian J; Tolksdorf F
    Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.